Skip to content
OpenCapital
Get started

Baxter International BAX Q1 2026 earnings

Reported April 30, 2026 · Before market open

Revenue$2.7BBeat by $85.5MDiluted EPS$0.36Beat by $0.05
Revenue estimate$2.6B
EPS estimate$0.31

Next report

Jul 30, 2026 (In 5 days)
Revenue estimate$2.8B
EPS estimate$0.36

Financials

Q1 2026

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%

Valuation & ratios

Valuation

as of 07/24/26
See full
Market cap$11.19B-24.2%
Enterprise value$9.4B-29.4%
P/S1×-0.4×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Segments

By product

See full
Infusion Therapies & Technologies$981.0M-1.3%
Care & Connectivity Solutions$435.0M+1.9%
Drug Compounding$320.0M+30.1%
Advanced Surgery$304.0M+13.4%
Injectables & Anesthesia$301.0M-10.1%

By segment

See full
Medical Products & Therapies$1.3B+1.8%
Healthcare Systems & Technologies$705.0M+0.1%
Pharmaceuticals$621.0M+6.9%

By geography

See full
International$1.3B—

Versus estimates

Revenue

Q1 2026$2.7BBeat by $85.5M
Q4 2025$3.0BBeat by $149.2MQ3 2025$2.8BBeat by $10.2MQ2 2025$2.8BMiss by $65.9MQ1 2025$2.6BBeat by $37.5MQ4 2024$10.6BBeat by $8.0B

Diluted EPS

Q1 2026$0.36Beat by $0.05
Q4 2025$0.44Miss by $0.09Q3 2025$0.69Beat by $0.09Q2 2025$0.59Miss by $0.01Q1 2025$0.55Beat by $0.07Q4 2024$0.58Beat by $0.05

Ask the moment Baxter International reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Baxter International report Q1 2026 earnings?
Baxter International (BAX) reported Q1 2026 earnings on April 30, 2026 before market open.
What were Baxter International's Q1 2026 revenue and EPS?
Baxter International reported revenue of $2.7B and diluted EPS of $0.36 for Q1 2026.
Did Baxter International beat estimates in Q1 2026?
Revenue beat the consensus estimate of $2.6B by $85.5M. EPS beat the consensus estimate of $0.31 by $0.05.
How did Baxter International's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.9% from $2.6B a year earlier and diluted EPS declined 34.5% from $0.55.
Where can I find Baxter International's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-028582) and the 10-Q periodic report (0001628280-26-028962) directly on SEC EDGAR. The filing index links above go to sec.gov.